Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of December 2015, with the report signed on January 8, 2016. The document serves as a disclosure of transactions involving the company's own securities and derivatives in compliance with Article 11 of CVM Instruction # 358/2002. It details changes in the company's treasury stock and American Depositary Receipts (ADRs).
Key Financial Metrics and Treasury Activity
The filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. Instead, it provides data on treasury share movements and option exercises:
- Treasury Shares (Common):
- Initial Balance: 35,080,552 shares (0.2232% of total shares).
- Final Balance: 32,520,980 shares (0.2069% of total shares).
- Net Change: Decrease of 2,559,572 shares.
- ADRs:
- Initial and Final Balance: 0 shares.
- Activity involved conversions and option exercises that netted to zero balance.
- Transaction Volumes (Common Shares):
- Total Sales (via Option Exercises and Deferred Shares): 1,894,240 shares for a total volume of R$ 12,307,259.72.
- Total Purchases (via Share Acquisition Plan): 168,172 shares for a total volume of R$ 3,128,773.33.
- ADRs Converted to Common Shares: 833,504 shares.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against a prior period. The primary material change reported is the reduction in the company's treasury stock of common shares, driven largely by the exercise of employee stock options and the conversion of ADRs, which exceeded the volume of shares repurchased under the Share Acquisition Plan.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is strictly a regulatory disclosure of specific securities transactions.
Important Facts for Investor Verification
- Verify the impact of the 2.56 million share reduction in treasury stock on the company's total outstanding share count and potential dilution.
- Confirm the pricing of option exercises, which ranged significantly (e.g., R$ 0.49 to R$ 9.36 per share), indicating different tranches or vesting periods.
- Note that the company executed a Share Acquisition Plan (buyback) totaling approximately R$ 3.1 million, but this was outweighed by shares issued via option exercises.
- Understand that this document does not reflect the company's operational performance for the quarter or year.